JP2007512260A5 - - Google Patents

Download PDF

Info

Publication number
JP2007512260A5
JP2007512260A5 JP2006540130A JP2006540130A JP2007512260A5 JP 2007512260 A5 JP2007512260 A5 JP 2007512260A5 JP 2006540130 A JP2006540130 A JP 2006540130A JP 2006540130 A JP2006540130 A JP 2006540130A JP 2007512260 A5 JP2007512260 A5 JP 2007512260A5
Authority
JP
Japan
Prior art keywords
treatment
type
heart
hypertension
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006540130A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007512260A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CH2004/000688 external-priority patent/WO2005051909A1/de
Publication of JP2007512260A publication Critical patent/JP2007512260A/ja
Publication of JP2007512260A5 publication Critical patent/JP2007512260A5/ja
Withdrawn legal-status Critical Current

Links

JP2006540130A 2003-11-28 2004-11-15 ｛Ｎ−［１−（Ｓ）−カルボアルコキシ−３−フェニルプロピル］−Ｓ−アラニル−２Ｓ，３ａＲ，７ａＳ−オクタヒドロインドール−２−カルボン酸｝化合物類の製造方法 Withdrawn JP2007512260A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH20382003 2003-11-28
PCT/CH2004/000688 WO2005051909A1 (de) 2003-11-28 2004-11-15 Verfahren zur herstellung von {n-[1-(s)-carbalkoxy-3-phenylpropyl]-s-alanyl-2s, 3ar, 7as-octahydroindol-2-carbonsäure}verbindungen

Publications (2)

Publication Number Publication Date
JP2007512260A JP2007512260A (ja) 2007-05-17
JP2007512260A5 true JP2007512260A5 (https=) 2007-12-06

Family

ID=34624414

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006540130A Withdrawn JP2007512260A (ja) 2003-11-28 2004-11-15 ｛Ｎ−［１−（Ｓ）−カルボアルコキシ−３−フェニルプロピル］−Ｓ−アラニル−２Ｓ，３ａＲ，７ａＳ−オクタヒドロインドール−２−カルボン酸｝化合物類の製造方法

Country Status (4)

Country Link
US (1) US20070135513A1 (https=)
EP (1) EP1689711A1 (https=)
JP (1) JP2007512260A (https=)
WO (1) WO2005051909A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008545006A (ja) * 2005-07-05 2008-12-11 シプラ・リミテッド Ａｃｅ阻害剤の合成方法
US7943655B2 (en) 2006-04-05 2011-05-17 Universitat Zurich Polymorphic and pseudopolymorphic forms of trandolaprilat, pharmaceutical compositions and methods for production and use
JP2012533563A (ja) 2009-07-16 2012-12-27 アボット ラボラトリーズ トランドラプリル用の中間体である（２Ｓ，３ａＲ，７ａＳ）−オクタヒドロ−１Ｈ−インドールカルボン酸の合成法
JP6889718B2 (ja) 2016-07-21 2021-06-18 株式会社カネカ 有機化合物の製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE55867B1 (en) * 1981-12-29 1991-02-14 Hoechst Ag New derivatives of bicyclic aminoacids,processes for their preparation,agents containing these compounds and their use,and new bicyclic aminoacids as intermediates and processes for their preparation
JPS6248696A (ja) * 1985-08-27 1987-03-03 Kanegafuchi Chem Ind Co Ltd Ｎ−〔１（ｓ）−エトキシカルボニル−３−フエニルプロピル〕−ｌ−アラニル−ｌ−プロリンの製造法
US6541635B1 (en) * 2002-03-29 2003-04-01 Everlight Usa, Inc. Method for producing angiotensin converting enzyme inhibitor

Similar Documents

Publication Publication Date Title
LTC1562603I2 (lt) Nauji vaistai, skirti lėtinių obstrukcinių plaučių ligų gydymui
NO20081016L (no) Nye 1-aryl-3-azabicyklo(3.1.0)heksaner, fremstilling og bruk for å behandle nevropsykiatriske lidelser
JP2003503454A5 (https=)
NO2017047I1 (no) Tofacitinib, evt. i form av et farmasøytisk akseptabelt salt, inkludert citratsalt
LT2878297T (lt) Medikamentai, skirti fibrozinių ligų gydymui arba prevencijai
JP2007522094A5 (https=)
JP2007514005A5 (https=)
NO20035496D0 (no) Substituerte sulfonamidforbindelser, fremgangsmåte for deres anvendelse sommedikament til behandling av CNS-forstyrrelser, overvekt og typeII-diabetes
JP2007523178A5 (https=)
EP1363625A4 (en) COMBINATIONS OF DRUGS (eg, BENZIMIDAZOLE AND PENTAMIDINE) IN THE TREATMENT OF NEOPLASTIC DISORDERS
NO2014030I2 (no) en kombinasjon av rilpivirine eller et farmasøytisk akseptabelt salt av rilpivirine innbefattende hydroklorid-saltet av rilpivirine, og emtricitabine.
JP2007520565A5 (https=)
ATE469131T1 (de) Sulfonamidderivate, ihre herstellung und ihre therapeutische anwendung
AP2378A (en) Sulfonamide derivatives for the treatment of diseases.
WO2007112014A3 (en) New therapeutic combinations for the treatment of depression
AP2359A (en) Sulfonamide derivatives for the treatment of diseases.
NO20062663L (no) Nukleinsyre som spesifikt binder bioaktivt ghrelin
JP2003526626A5 (https=)
JP2005509503A5 (https=)
WO2005060949A3 (en) Selective norepinephrine reuptake inhibitors for the treatment of hot flashes, impulse control disorders and personality change due to a general medical condition
RU2004116622A (ru) Способ нормализации тромбоцитарных нарушений при метаболическом синдроме
JP2007512260A5 (https=)
JP2008519810A5 (https=)
DK1753725T3 (da) Tetra-hydro-iso-quinolinsulfonamidderivater, fremstilling og terapeutisk anvendelse heraf.
WO2007078271A3 (en) Lansoprazole orally disintegrating tablets